Comments on 'Adaptive increase in sample size when interim results are promising: A practical guide with examples'

Statistics in Medicine

Volumn 30, Issue 28, 2011, Pages 3285-3301

  Emerson, Scott S ^a   Levin, Gregory P ^a   Emerson, Sarah C ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

Adaptive design; Clinical trial; Group sequential test; Group sequential trial; Statistical efficiency

Indexed keywords

ACCURACY; ADAPTIVE SAMPLE SIZE REESTIMATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; INFERENTIAL STATISTICS; LIMIT OF QUANTITATION; NOTE; OUTCOMES RESEARCH; PREDICTIVE VALUE; PROBABILITY; PRODUCTIVITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEIVER OPERATING CHARACTERISTIC; SAMPLE SIZE; SEQUENTIAL ANALYSIS; STATISTICAL DISTRIBUTION; STUDY DESIGN;

CLINICAL TRIALS, PHASE III AS TOPIC; EPIDEMIOLOGIC RESEARCH DESIGN; HUMANS; MODELS, STATISTICAL;

EID: 82055196645     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.4271     Document Type: Note

References (28)

1. Mehta CR, Pocock SJ. Adaptive increase in sample size when interim results are promising: A practical guide with examples. Statistics in Medicine 2011.
2. Gao P, Ware J, Mehta C. Sample size re-estimation for adaptive sequential design in clinical trials. Journal of Biopharmaceutical Statistics 2008; 18(6):1184-1196.
3. Emerson SS. Issues in the use of adaptive clinical trial designs. Statistics in Medicine 2006; 25(19):3270-3296.
4. Emerson SS, Fleming TR. Adaptive methods: telling 'the rest of the story'. Journal of Biopharmaceutical Statistics 2010; 20:1150-1165.
5. Emerson SS, Kittelson JM, Gillen DL. Frequentist evaluation of group sequential designs. Statistics in Medicine 2007; 26(28):5047-5080.
6. Emerson SS, Kittelson JM, Gillen DL. Bayesian evaluation of group sequential designs. Statistics in Medicine 2007; 26(7):1431-1449.
7. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979; 35:549-556.
8. Emerson SC, Rudser KD, Emerson SS. Exploring the benefits of adaptive sequential designs in time-to-event endpoint settings. Statistics in Medicine 2011.
9. Kittelson JM, Sharples K, Emerson SS. Group sequential clinical trials for longitudinal data with analyses using summary statistics. Statistics in Medicine 2005; 24(16):2457-2475.
10. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983; 70(3):659-663.
11. Burington BE, Emerson SS. Flexible implementations of group sequential stopping rules using constrained boundaries. Biometrics 2003; 59:770-777.
12. Mehta CR, Tsiatis AA. Flexible sample size considerations using information-based interim monitoring. Drug Information Journal 2001; 35(4):1095-1112.
13. Pampallona S, Tsiatis AA, Kim K. Interim monitoring of group sequential trials using spending functions for the type I and type II error probabilities. Drug Information Journal 2001; 35(4):1113-1121.
14. Bauer P, Köhne K. Evaluation of experiments with adaptive interim analyses. Biometrics 1994; 50:1029-1041.
15. Proschan MA, Hunsberger SA. Designed extension of studies based on conditional power. Biometrics 1995; 51:1315-1324.
16. Fisher LD. Self-designing clinical trials. Statistics in Medicine 1998; 17(14):1551-1562.
17. Cui L, Hung HMJ, Wang SJ. Modification of sample size in group sequential clinical trials. Biometrics 1999; 55:853-857.
18. Müller HH, Schäfer H. Adaptive group sequential designs for clinical trials: combining the advantages of adaptive and of classical group sequential approaches. Biometrics 2001; 57(3):886-891.
19. Armitage P, McPherson CK, Rowe BC. Repeated significance tests on accumulating data. Journal of the Royal Statistical Society, Series A 1969; 132(2):235-244.
20. Pocock SJ. Group sequential methods in the design and analysis of clinical trials. Biometrika 1977; 64:191-200.
21. Tsiatis AA, Mehta CR. On the inefficiency of the adaptive design for monitoring clinical trials. Biometrika 2003; 90:367-378.
22. Jennison C, Turnbull BW. Mid-course sample size modification in clinical trials based on the observed treatment effect. Statistics in Medicine 2003; 22(6):971-993.
23. Kittelson JM, Emerson SS. A unifying family of group sequential test designs. Biometrics 1999; 55:874-882.
24. Levin GP, Emerson SC, Emerson SS. Adaptive clinical trial designs with pre-specified rules for modifying the sample size: Understanding efficient types of adaptation. UW Biostatistics Working Paper Series. Working Paper 377. Available from: .
25. Emerson SS, Kittelson JM, Gillen DL. On the use of stochastic curtailment in group sequential clinical trials. UW Biostatistics Working Paper Series, 2005.
26. Emerson SC. Application of group sequential estimation methods to adaptive designs. Technical Report, Oregon State University, Department of Statistics, 2011.
27. Tsiatis AA, Rosner GL, Mehta CR. Exact confidence intervals following a group sequential test. Biometrics 1984; 40:797-803.
28. Emerson SS, Fleming TR. Parameter estimation following group sequential hypothesis testing. Biometrika 1990; 77:875-892.